US 9072732
Indication for use of niacin (nicotinic acid) for treatment and reversal of fatty liver disease
granted A61KA61K31/455A61K45/06
Quick answer
US patent 9072732 (Indication for use of niacin (nicotinic acid) for treatment and reversal of fatty liver disease) held by The Regents of the University of California expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/455, A61K45/06